Tyrosine kinase inhibitors suppress prostaglandin F(2α)-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle

European Journal of Pharmacology

Volumn 360, Issue 2-3, 1998, Pages 185-193

  Yousufzai, Sardar Y K ^a   Abdel Latif, Ata A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Carbachol; Nonvascular smooth muscle, nonvascular; Prostaglandin F(2 ); Tyrosine phosphorylation

Indexed keywords

CALCIUM ION; CARBACHOL; DAIDZEIN; GENISTEIN; HERBIMYCIN; LATANOPROST; PHOSPHATIDYLINOSITIDE; PROSTAGLANDIN F2 ALPHA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN; VANADIC ACID; WORTMANNIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CAT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GLAUCOMA; HYDROLYSIS; INTRAOCULAR PRESSURE; IRIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTION;

ANIMALS; CALCIUM; CARBACHOL; CARDIOTONIC AGENTS; CATS; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENISTEIN; HYDROLYSIS; IRIS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHOSPHATIDYLINOSITOLS; PROSTAGLANDINS F, SYNTHETIC; PROTEIN-TYROSINE KINASES; VANADATES;

EID: 0032491504     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00697-9     Document Type: Article

References (47)

1. Abdel-Latif A.A. Release and effects of prostaglandins in ocular tissues. Prostaglandins Leukotrienes Essent. Fatty Acids. 44:1991;71-82.
2. Abdel-Latif A.A. Cross talk between cyclic cAMP and the polyphosphoinositide signaling cascade in iris sphincter and other nonvascular smooth muscle. Proc. Soc. Exp. Biol. Med. 211:1996;163-176.
3. Abramowitz M., Boie Y., Nguyen T., Rushmore T.H., Bayne M.A., Metters K.M., Slipetz D.M., Grygorzyk R. Cloning and expression of a cDNA for the human prostanoid FP receptor. J. Biol. Chem. 269:1994;2632-2636.
4. Akiyama, T., Ishida, J., Nakagawa, S., Ogamara, H., Watanabe, S.-I., Ito, N., Shibuya, M., Fukami, Y., 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases 262, pp. 5592-5595.
5. 2α receptors in the human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 39:1998;315-321.
6. Berridge M.J. Inositol trisphosphate and calcium signaling. Nature. 361:1993;315-325.
7. Bhatacherjee P., Rhodes L., Paterson C.A. Prostaglandin receptors coupled to adenylyl cyclase in the iris-ciliary body of rabbits, cats and cows. Exp. Eye Res. 56:1993;327-333.
8. 2α analog, PhXA41 (latanoprost), for glaucoma management. J. Lipid Mediators. 6:1993;535-543.
9. Coleman, R.A., Kennedy, I., Humprey, P.P.A., Bunce, K., Lumley, P., 1990. Prostanoids and their receptors. In: Hansch, C., Sammes, P.G., Taylor, J.B. (Eds), Comprehensive Medicinal Chemistry. Pergamon, Oxford, pp. 643-714.
10. 2α. Arch. Ophthalmol. 105:1987;1112-1116.
11. 2+ mobilization in cat iris sphincter smooth muscle cells by cAMP-elevating agents. Cell. Signal. 9:1997;411-421.
12. 1. FEBS Letters. 422:1998;85-88.
13. Di Salvo J., Semenchuk L.A., Lauer J. Vanadate-induced contraction of smooth muscle and enhanced protein tyrosine phosphorylation. Arch. Biochem. Biophys. 304:1993;386-391.
14. Di Salvo J., Steusloff A., Semenchuk L., Satoh S., Kolquist K., Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Commun. 190:1993;968-974.
15. Di Salvo J., Nelson S.R., Kaplan N. Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc. Soc. Exp. Biol. Med. 214:1997;285-301.
16. 2α on porcine ciliary muscle cells in culture. Curr. Eye Res. 14:1995;1155-1163.
17. Fukazawa H., Li P.-M., Yamamoto C., Murakami Y., Mizuno S. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro. Biochem. Pharmacol. 42:1991;1661-1671.
18. Gazit A., Yaish P., Gilon C., Levitzki A. Tyrphostin: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32:1989;2344-2352.
19. 2+mobilization in swine carotid artery. Am. J. Physiol. 268:1995;1425-1429.
20. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
21. 2α stimulates tyrosine phosphorylation and mitogen-activated protein kinase in osteoblastic MC3T3-E1 cells via protein kinase C activation. Endocrinology. 138:1997;1821-1828.
22. Hollenburg M.D. Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci. 15:1994;108-114.
23. Howe P.H., Akhtar R.A., Naderi S., Abdel-Latif A.A. Correlative studies on the effect of carbachol on myo-inositol trisphosphate accumulation, myosin light chain phosphorylation and contraction in sphincter smooth muscle of rabbit iris. J. Pharmacol. Exp. Ther. 239:1986;574-583.
24. Kamm K.E., Stull J.T. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu. Rev. Pharmacol. Toxicol. 25:1985;593-620.
25. Krauss A.H.P., Wiederholt M., Sturm A., Woodward D.F. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Exp. Eye Res. 64:1997;447-453.
26. 2α receptor. J. Biol. Chem. 272:1997;27147-27154.
27. 2α receptor. FEBS Letters. 355:1994;317-325.
28. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
29. Molloy C.J., Taylor D.S., Webers H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268:1993;7338-7345.
30. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., Yamada K., Yoshida M., Kage K., Matsuda Y., Hashimoto Y., Nonomura Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267:1992;2157-2163.
31. Ocklind A., Yousufzai S.Y.K., Ghosh S., Coca-Prados M., stjernschantz J., Abdel-Latif A.A. Immortalization of cat iris sphincter smooth muscle cells by SV40 virus: growth, morphological, biochemical and pharmacological characteristics. Exp. Eye Res. 61:1995;535-545.
32. 2α receptor messenger RNA and protein in the cynomolgus monkey eye. Invest. Ophthalmol. Vis. Sci. 37:1996;716-726.
33. Ohia S.E., Jumblatt J.E. Prejunctional prostaglandin receptors in the human iris-ciliary body. Curr. Eye Res. 10:1991;967-975.
34. 1. Biology of Reproduction. 54:1996;1383-1389.
35. Pierce K.L., Baily T.J., Hoyer P.B., Gil D.W., Woodward D.F., Regan J.W. Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor. J. Biol. Chem. 272:1997;883-887.
36. 2α-induced mitogenesis in MC3T3-E1 osteoblasts: role of protein kinase C-mediated tyrosine phosphorylation. Endocrinology. 132:1993;1505-1513.
37. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272:1997;15045-15048.
38. 2α receptor. J. Biol. Chem. 269:1994;3881-3886.
39. 2α analogue. Advances in prostaglandin. Thromboxane and Leukotriene Res. 23:1995;513-518.
40. Sugimoto Y., Hasumoto K., Namba T., Irie A., Katsuyama M., Negishi M., Kakizuka A., Narumiya S., Ichikawa A. Cloning and expression of a cDNA for mouse prostaglandin FP receptor. J. Biol. Chem. 269:1994;1356-1360.
41. 2+ level and force in vascular smooth muscle. Jpn. J. Pharmacol. 64:1994;216P. Abstract.
42. Tonks N.K., Diltz C.D., Fischer E.H. Purification of the major protein-tyrosine-phophatases of human placenta. J. Biol. Chem. 263:1988;6722-6730.
43. 2+-dependent intracellular pathway in NIH-3T3 cells. J. Biol. Chem. 269:1994;17619-17625.
44. Wiederholt M., Groth J., Strauss O. Role of protein tyrosine kinase on regulation of trabecular meshwork and ciliary muscle contractility. Invest. Ophthalmol. Vis. Sci. 39:1998;1012-1020.
45. Yang S.-G., Saifeddine M., Hollenberg M.D. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastron and other agonists in gastric smooth muscle. Can. J. Physiol. Pharmacol. 70:1992;85-93.
46. Yang S.-G., Saifeddine M., Laniyonu A., Hollenberg M.D. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: differential blockade by indomethacin and tyrosine kinase inhibitors. J. Pharmacol. Exp. Ther. 264:1993;958-966.
47. Yousufzai S.Y.K., Chen A.-L., Abdel-Latif A.A. Species differences in the effects of prostaglandins on inositol trisphosphate accumulation, phosphatidic acid formation, myosin light chain phosphorylation and contraction in iris sphincter of the mammalian eye: interaction with the cAMP system. J. Pharmacol. Exp. Ther. 247:1988;1064-1072.